United States

Catalyst Biosciences is a biopharmaceutical company focused on developing protease product candidates for hemostasis and complement regulation. Their platform creates improved molecules to treat diseases resulting from complement system dysregulation. They are developing treatments for dry age-related macular degeneration and deficiencies in complement factor I. They also have platforms targeting other complement or inflammatory disorders. They have collaborations with Mosaic Biosciences and Biogen International. Founded in 2002, Catalyst Biosciences is headquartered in South San Francisco.

Catalyst Bioscience

Developing protease products for diseases.

Google

Produktu vadītājs

Datu zinātnieks

Catalyst Bioscience

Catalyst Bioscience Brīvas vakances

Vai esat gatavi pacelt savu karjeru nākamajā līmenī? Apskatiet šīs brīvās vakances uzņēmumā Catalyst Bioscience.